Unknown OBSERVATIONAL NCT00126958

Cost-Effectiveness in Bladder Cancer

Cost-Effectiveness of Follow-up of Patients With Superficial Bladder Cancer

Sponsor: Albert Schweitzer Hospital, Netherlands

Updated 8 times since 2017 Last updated: Feb 18, 2009 Started: Jul 31, 2002 Completion: Jul 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Bladder Cancer, this trial is ongoing. The trial is conducted by Albert Schweitzer Hospital, Netherlands and has accumulated 8 data snapshots since 2002. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Dec 2024 — Present [monthly]

Unknown
Sep 2024 — Dec 2024 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Feb 2019 — Jan 2021 [monthly]

Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Feb 2019 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: PHASE4 → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status PHASE4

First recorded

Jul 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Albert Schweitzer Hospital, Netherlands
Erasmus Medical Center
Havenziekenhuis
Ikazia Hospital, Rotterdam
Leiden University Medical Center
Medisch Centrum Rijnmond-Zuid, Netherlands
Reinier de Graaf Groep
Sint Franciscus Gasthuis
Vlietland Ziekenhuis
ZonMw: The Netherlands Organisation for Health Research and Development

Data source: Erasmus Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.